DOI: https://dx.doi.org/10.18565/therapy.2025.1.64-73
Shokhin A.A., Trofimova A.S., Trofimov E.A.
1) Severodvinsk City Hospital No. 1; 2) I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia, Saint Petersburg
1. Клиническая ревматология. Руководство для врачей. 3-е издание, переработанное и дополненное. Под ред. В.И. Мазурова. М.: Е-ното. 2021; 696 с. (Clinical rheumatology. Guide for doctors. 3rd edition, revised and enlarged. Ed. by Mazurov V.I. Moscow: E-noto. 2021; 696 pp. (In Russ.)). ISBN: 978-5-906023-26-1. 2. World Health Organization. Chronic rheumatic conditions. 2020. URL: https://web.archive.org/web/20150427154245/http://www.who.int/chp/topics/rheumatic/en (date of access – 12.02.2025). 3. Felson D.T., Lawrence R.C., Dieppe P.A. et al. Osteoarthritis: New insights. Part 1: The disease and its risk factors. Ann Intern Med. 2000; 133(8): 635–46. https://doi.org/10.7326/0003-4819-133-8-200010170-00016. PMID: 11033593. 4. Российские клинические рекомендации. Ревматология. Под ред. академика РАН Е.Л. Насонова. М.: ГЭОТАР-Медиа. 2020; 448 с. (Russian clinical guidelines. Rheumatology. Ed. by academician of RAS Nasonov E.L. Moscow: GEOTAR-Media. 2020; 448 pp. (In Russ.)). ISBN: 978-5-9704-5398-8. 5. Felson D.T. Clinical practice. Osteoarthritis of the knee. N Engl J Med. 2006; 354(8): 841–48. https://doi.org/10.1056/NEJMcp051726. PMID: 16495396. 6. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011; 23(5): 471–78. https://doi.org/10.1097/BOR.0b013e328349c2b1. PMID: 21788902. PMCID: PMC3937875. 7. Kapoor M., Martel-Pelletier J., Lajeunesse D. et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011; 7(1): 33–42. https://doi.org/10.1038/nrrheum.2010.196. PMID: 21119608. 8. Sandell L.J., Aigner T. Articular cartilage and changes in arthritis. An introduction: Cell biology of osteoarthritis. Arthritis Res. 2001; 3(2): 107–13. https://doi.org/10.1186/ar148. PMID: 11178118. PMCID: PMC128887. 9. Lumeng C.N., Saltiel A.R. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011; 121(6): 2111–17. https://doi.org/10.1172/JCI57132. PMID: 21633179. PMCID: PMC3104776. 10. Dieppe P.A., Lohmander L.S. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005; 365(9463): 965–73. https://doi.org/10.1016/S0140-6736(05)71086-2. PMID: 15766999. 11. Трофимова А.С., Мазуров В.И., Шохин А.А., Трофимов Е.А. Применение симптоматических средств замедленного действия при остеоартрите суставов кистей: акцент на параметры микроциркуляции. Научно-практическая ревматология. 2024; 62(1): 104–108. (Trofimova A.S., Mazurov V.I., Shokhin A.A., Trofimov E.A. The use of symptomatic slow-acting drugs for osteoarthritis of the joints of the hands: accent on microcirculation parameters. Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2024; 62(1): 104–108 (In Russ.)). https://doi.org/10.47360/1995-4484-2024-104-108. EDN: KOMTFW. 12. Burr D.B., Gallant M.A. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012; 8(11): 665–73. https://doi.org/10.1038/nrrheum.2012.130. PMID: 22868925. 13. Насонова В.А., Мендель О.И., Денисов Л.Н. с соавт. Остеоартроз и ожирение: клинико-патогенетические взаимосвязи. Профилактическая медицина. 2011; 14(1): 29–37. (Nasonova V.A., Mendel’ O.I., Denisov L.N. et al. Osteoarthrosis and obesity: Clinical and pathogenetic associations. Profilakticheskaya meditsina = Russian Journal of Preventive Medicine. 2011; 14(1): 29–37 (In Russ.)). EDN: PUGJDV. 14. McWilliams D.F., Leeb B.F., Muthuri S.G. et al. Occupational risk factors for osteoarthritis of the knee: A meta-analysis. Osteoarthritis Cartilage. 2011; 19(7): 829–839. https://doi.org/10.1016/j.joca.2011.02.016. PMID: 21382500. 15. Шохин А.А., Трофимов Е.А. Остеоартрит, ассоциированный с профессией: современное представление проблемы. В кн.: Боткинские чтения. Сборник тезисов Всероссийского терапевтического конгресса с международным участием. СПб. 2024; 271–272. (Shokhin A.A., Trofimov E.A. Occupational osteoarthritis: Modern view of the problem. In the book: Botkin readings. Collection of articles abstracts of the All-Russian therapeutic congress with international participation. Saint Petersburg. 2024; 271–272 (In Russ.)). EDN: CKUDTW. 16. Лила А.М., Алексеева Л.И., Таскина Е.А. Современные подходы к терапии остеоартрита с учетом обновленных международных рекомендаций. РМЖ. Медицинское обозрение. 2019; 3(11-2): 48–52. (Lila A.M., Alekseeva L.I., Taskina E.A. Modern approaches to osteoarthritis therapy taking into account updated international guidelines. Russkiy meditsisnkiy zhurnal. Meditsinskoye obozreniye = Russian Medical Journal. Medical Review. 2019; 3(11-2): 48–52 (In Russ.)). EDN: ZBVXMF. 17. Primorac D., Molnar V., Rod E. et al. Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations. Genes (Basel). 2020; 11(8): 854. https://doi.org/10.3390/genes11080854. PMID: 32722615. PMCID: PMC7464436. 18. Самусев С.Р., Маланин Д.А., Новочадов В.В., Беликов А.А. Комплексная оценка эффективности вискосапплиментарной терапии у больных с гонартрозом. Волгоградский научно-медицинский журнал. 2008; (4): 51–55. (Samusev S.R., Malanin D.A., Novoсhadov V.V., Belikov A.A. Comprehensive assessment of the effectiveness of viscosupplementation therapy in patients with gonarthrosis. Volgogradskiy nauchno-meditsinskiy zhurnal = Volgograd Scientific Medical Journal. 2008; (4): 51–55 (In Russ.)). EDN: TRPKGR. 19. Sánchez M., Anitua E., Padilla S. et al. Plasma rich in growth factors for the treatment of osteoarthritis: An overview of the clinical evidence. BioDrugs. 2019; 33(4): 305–19. 20. Altman R.D., Manjoo A., Fierlinger A. et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: A systematic review. BMC Musculoskelet Disord. 2015; 16: 321. https://doi.org/10.1186/s12891-015-0775-z. PMID: 26503103. PMCID: PMC4621876. 21. Filardo G., Kon E., Buda R. et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: From preclinical to clinical evidence. Arthroscopy. 2015; 31(11): 2053–63. 22. Campbell K.A., Saltzman B.M., Mascarenhas R. et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015; 31(11): 2213–21. https://doi.org/10.1016/j.arthro.2015.03.041. PMID: 26033459. 23. Toghraie F., Rashtchi V., Dehghani S. et al. Platelet-rich plasma for the treatment of knee osteoarthritis: An overview of systematic reviews. Orthop Res Rev. 2019; 11: 55–68. 24. Yu W., Xu P., Huang G., Liu L. Clinical therapy of hyaluronic acid combined with platelet‑rich plasma for the treatment of knee osteoarthritis. Exp Ther Med. 2018; 16(3): 2119–25. https://doi.org/10.3892/etm.2018.6412. PMID: 30186448. PMCID: PMC6122407. 25. Стребкова Е.А., Алексеева Л.И. Остеоартроз и ожирение. Научно-практическая ревматология. 2015; 53(5): 542–552. (Strebkova E.A., Alekseeva L.I. Osteoarthritis and obesity. Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2015; 53(5): 542–552 (In Russ.)). https://doi.org/10.14412/1995-4484-2015-542-552. EDN: UMIDVF. 26. Прохорова И.Е., Артеменко Н.А., Багмет А.Д. Клинические и лабораторные особенности течения остеоартроза у пациентов с ожирением. Военно-медицинский журнал. 2009; 220(3): 73. (Prokhorova I.E., Artemenko N.A., Bagmet A.D. Clinical and laboratory features of osteoarthritis in patients with obesity. Voenno-meditsinskiy zhurnal = Military Medical Journal. 2009; 220(3): 73 (In Russ.)). EDN: STTWBZ. 27. Faletti C., Mussa F., Autelli R. et al. Nonpharmacological treatments and lifestyle interventions in osteoarthritis. J Orthop Traumatol. 2020; 21(2): 45–52. 28. Bindu S., Mazumder S., Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180: 114147. https://doi.org/10.1016/j.bcp.2020.114147. PMID: 32653589. PMCID: PMC7347500. 29. Guler O., Mutlu S., Isyar M. et al. Comparison of short-term results of intraarticular platelet-rich plasma (PRP) and hyaluronic acid treatments in early-stage gonarthrosis patients. Eur J Orthop Surg Traumatol. 2015; 25(3): 509–13. https://doi.org/10.1007/s00590-014-1517-x. PMID: 25085316. 30. Pavelka K., Bruyère O., Cooper C. et al. Diacerein: Benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs Aging. 2016; 33(2): 75–85. https://doi.org/10.1007/s40266-016-0347-4. PMID: 26849131. PMCID: PMC4756045. 31. Moldovan F., Pelletier J.P., Jolicoeur F.C. et al. Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis Cartilage. 2000; 8(3): 186–96. https://doi.org/10.1053/joca.1999.0289. PMID: 10806046.
Andrey A. Shokhin, MD, rheumatologist at Severodvinsk City Hospital No. 1. Address: 164504, Severodvinsk, 47 Lomonosova St.
E-mail: andra.11@yandex.ru
ORCID: https://orcid.org/0009-0000-5440-237X. eLibrary SPIN: 8922-1101
Anna S. Trofimova, MD, PhD (Medicine), assistant at the Department of therapy, rheumatology, examination of temporary disability and quality of medical care with a course in hematology and transfusiology named after E.E. Eichwald, I.I. Mechnikov North-West State Medical University of the Ministry of Healthcare of Russia. Address: 191015, Saint Petersburg, 41 Kirochnaya St.
E-mail: Anna.Trofimova@szgmu.ru
ORCID: https://orcid.org/0000-0001-5926-7912. eLibrary SPIN: 6827-3934
Evgeny A. Trofimov, MD, Dr. Sci. (Medicine), professor, professor of the Department of therapy, rheumatology, examination of temporary disability and quality of medical care with a course in hematology and transfusiology named after E.E. Eichwald, I.I. Mechnikov North-West State Medical University of the Ministry of Healthcare of Russia. Address: 191015, Saint Petersburg, 41 Kirochnaya St.
E-mail: Evgeniy.trofimov@szgmu.ru
ORCID: https://orcid.org/0000-0003-3236-4485. eLibrary SPIN: 4358-1663